Ep162: Sean McClain on AI for Biologic Drug Discovery
The Long Run with Luke Timmerman
Exploration of Drug Discovery through Unexpected Discoveries
Exploring a serendipitous point mutation that increased affinity in drug compounds rather than titer, leading to the utilization of the ACE assay for rapid evaluation of drug affinity and revolutionizing the biologics development process.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
